Certepetide

Modify Date: 2025-09-26 12:43:39

Certepetide Structure
Certepetide structure
Common Name Certepetide
CAS Number 2580154-02-3 Molecular Weight 989.09
Density N/A Boiling Point N/A
Molecular Formula C37H60N14O14S2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Certepetide


Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary drug conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors[1][2][3].

 Names

Name Certepetide

 Certepetide Biological Activity

Description Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary drug conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors[1][2][3].
Related Catalog
Target

Alphav-integrins, NRP-1[3].

References

[1]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl127.pdf?sfvrsn=8544ca1e_3&download=true

[2]. Ruoslahti Erkki, et al. Methods for treating pancreatic cancer and other solid tumors. WO2021226148.

[3]. Andrew Peter Dean, et al. Updated single institution outcome data from the first-in-human CEND-1 trial in metastatic pancreatic cancer. Journal of Clinical Oncology 2021 39:15_suppl, e16274-e16274

 Chemical & Physical Properties

Molecular Formula C37H60N14O14S2
Molecular Weight 989.09
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.